Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;45(4):385-91, 391e1-2.
doi: 10.1038/ng.2560.

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

Rosalind A Eeles  1 Ali Amin Al OlamaSara BenllochEdward J SaundersDaniel A LeongamornlertMalgorzata TymrakiewiczMaya GhoussainiCraig LuccariniJoe DennisSarah Jugurnauth-LittleTokhir DadaevDavid E NealFreddie C HamdyJenny L DonovanKen MuirGraham G GilesGianluca SeveriFredrik WiklundHenrik GronbergChristopher A HaimanFredrick SchumacherBrian E HendersonLoic Le MarchandSara LindstromPeter KraftDavid J HunterSusan GapsturStephen J ChanockSonja I BerndtDemetrius AlbanesGerald AndrioleJohanna SchleutkerMaren WeischerFederico CanzianElio RiboliTim J KeyRuth C TravisDaniele CampaSue A InglesEsther M JohnRichard B HayesPaul D P PharoahNora PashayanKay-Tee KhawJanet L StanfordElaine A OstranderLisa B SignorelloStephen N ThibodeauDan SchaidChristiane MaierWalther VogelAdam S KibelCezary CybulskiJan LubinskiLisa Cannon-AlbrightHermann BrennerJong Y ParkRadka KanevaJyotsna BatraAmanda B SpurdleJudith A ClementsManuel R TeixeiraEd DicksAndrew LeeAlison M DunningCaroline BaynesDon ConroyMelanie J MaranianShahana AhmedKoveela GovindasamiMichelle GuyRosemary A WilkinsonEmma J SawyerAngela MorganDavid P DearnaleyAlan HorwichRobert A HuddartVincent S KhooChristopher C ParkerNicholas J Van AsChristopher J WoodhouseAlan ThompsonTim DudderidgeChris OgdenColin S CooperArtitaya LophatananonAngela CoxMelissa C SoutheyJohn L HopperDallas R EnglishMarkus AlyJan AdolfssonJiangfeng XuSiqun L ZhengMeredith YeagerRudolf KaaksW Ryan DiverMia M GaudetMariana C SternRoman CorralAmit D JoshiAhva ShahabiTiina WahlforsTeuvo L J TammelaAnssi AuvinenJarmo VirtamoPeter KlarskovBørge G NordestgaardM Andreas RøderSune F NielsenStig E BojesenAfshan SiddiqLiesel M FitzgeraldSuzanne KolbErika M KwonDanielle M KaryadiWilliam J BlotWei ZhengQiuyin CaiShannon K McDonnellAntje E RincklebBettina DrakeGraham ColditzDominika WokolorczykRobert A StephensonCraig TeerlinkHeiko MullerDietrich RothenbacherThomas A SellersHui-Yi LinChavdar SlavovVanio MitevFelicity LoseSrilakshmi SrinivasanSofia MaiaPaula PauloEthan LangeKathleen A CooneyAntonis C AntoniouDaniel VincentFrançois BacotDaniel C TessierCOGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) InitiativeAustralian Prostate Cancer BioresourceUK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of OncologyUK ProtecT (Prostate testing for cancer and Treatment) Study CollaboratorsPRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) ConsortiumZsofia Kote-JaraiDouglas F Easton
Affiliations

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

Rosalind A Eeles et al. Nat Genet. 2013 Apr.

Abstract

Prostate cancer is the most frequently diagnosed cancer in males in developed countries. To identify common prostate cancer susceptibility alleles, we genotyped 211,155 SNPs on a custom Illumina array (iCOGS) in blood DNA from 25,074 prostate cancer cases and 24,272 controls from the international PRACTICAL Consortium. Twenty-three new prostate cancer susceptibility loci were identified at genome-wide significance (P < 5 × 10(-8)). More than 70 prostate cancer susceptibility loci, explaining ∼30% of the familial risk for this disease, have now been identified. On the basis of combined risks conferred by the new and previously known risk loci, the top 1% of the risk distribution has a 4.7-fold higher risk than the average of the population being profiled. These results will facilitate population risk stratification for clinical studies.

PubMed Disclaimer

Conflict of interest statement

COMPETING FINANCIAL INTERESTS

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 3
Figure 3
Figure 3
Figure 3
Figure 3
Figure 3

Comment in

References

    1. Goh CL, et al. Genetic variants associated with predisposition to prostate cancer and potential clinical implications. J Intern Med. 2012;271:353–365. - PubMed
    1. Akamatsu S, et al. Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese. Nat Genet. 2012;44:426–429. - PubMed
    1. Gudmundsson J, et al. Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility. Nat Genet. 2009;41:1122–1126. - PMC - PubMed
    1. Xu J, et al. Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet. 2012;44:1231–1235. - PMC - PubMed
    1. Amin Al Olama A, et al. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet. 2013;22:408–415. - PMC - PubMed